SEC Comment Letter 0000000000-24-005542 to BIOTRICITY INC. (BTCY) (CIK 0001630113) (BTCY)

BIOTRICITY INC. (BTCY) (CIK 0001630113)
Date: May 14, 2024 · CIK: 0001630113 · Accession: 0000000000-24-005542

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-279226

Date

May 14, 2024

Author

Division of Corporation Finance

Form

UPLOAD

Company

BIOTRICITY INC. (BTCY) (CIK 0001630113)

Letter

United States securities and exchange commission logo May 14, 2024 Waqaas Al-Siddiq Chief Executive Officer Biotricity Inc. 203 Redwood Shores Parkway, Suite 600 Redwood City, CA 94065

Re: Biotricity Inc. Registration Statement on Form S-3 Filed May 8, 2024 File No. 333-279226

Dear Waqaas Al-Siddiq:

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Conlon Danberg at 202-551-4466 with any questions.

Sincerely,
Division of Corporation Finance

Show Raw Text

<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
United States securities and exchange commission logo

                         May 14, 2024

       Waqaas Al-Siddiq
       Chief Executive Officer
       Biotricity Inc.
       203 Redwood Shores Parkway, Suite 600
       Redwood City, CA 94065

                                                        Re: Biotricity Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed May 8, 2024
                                                            File No. 333-279226

       Dear Waqaas Al-Siddiq:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Conlon
Danberg at 202-551-4466 with any questions.

                         Sincerely,

                         Division of Corporation Finance

                         Office of Industrial Applications and

                         Services
       cc:                                              David B. Manno, Esq.
</TEXT>
</DOCUMENT>

SecProbe.io